Utah Medical Products
UTMD
76 hedge funds and large institutions have $179M invested in Utah Medical Products in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 8 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 21
16% more capital invested
Capital invested by funds: $155M → $179M (+$24.5M)
0.89% less ownership
Funds ownership: 67.49% → 66.6% (-0.89%)
1% less funds holding
Funds holding: 77 → 76 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$2.58M |
| 2 |
Renaissance Technologies
New York
|
+$1.44M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.04M |
| 4 |
Millennium Management
New York
|
+$702K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$531K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
-$4.05M |
| 2 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$3.7M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$611K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$346K |
| 5 |
Goldman Sachs
New York
|
-$273K |
UTMD Hedge Fund Activity: Q2 2017 in Review
76 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2017, worth a combined $179M — up 16% from $155M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of UTMD and 7 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 31 added.
The largest buyer was Brandes Investment Partners, opening a new position worth an estimated $2.58M. The largest seller was Credit Agricole, exiting entirely with an estimated $4.05M sold.
- 76 institutional investors held Utah Medical Products (UTMD) as of Q2 2017, down from 77 in Q1 2017.
- Funds reported $179M of Utah Medical Products stock for Q2 2017, up 16% quarter-over-quarter.
- 7 funds opened new Utah Medical Products positions in Q2 2017 and 8 closed out, a net change of -1 holder.
- The largest Utah Medical Products buyer in Q2 2017 was Brandes Investment Partners, an estimated $2.58M added.
- The largest Utah Medical Products seller in Q2 2017 was Credit Agricole, an estimated $4.05M sold.
Based on aggregated 13F filings for Q2 2017.